Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Search by Keyword
Sort By
  • Contains 33 Component(s), Includes Credits

    Live activity to be held in Las Vegas in March 2024

    This is a live activity to be held in Las Vegas, Nevada on March 8 - 9 2024. Topics will include:

    - Multi-omic Approaches to Unraveling MASLD
    - Precision medicine in MASLD- From big data to the individual
    - Precision biomarkers for MASH and fibrosis
    - Precision medicine in MASLD diagnostics
    - Precision MASLD care today and looking ahead to 2034

    This activity will be offering CME/MOC credits:

    Continuing Medical Education Credit (CME)

    Accreditation Statement: The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Designation Statement: AASLD designates this enduring activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Board of Internal Medicine Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation components, enables the participant to earn up to 12.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Contains 15 Component(s)

    SIG Presentations

    This activity holds all Special Interest Group (SIG) presentations from The Liver Meeting 2023.

  • Contains 4 Product(s)

    View on-demand presentations from The Liver Meeting® 2023. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics.

    This package will include:

    • The Postgraduate Course:  Cirrhosis As a Multisystem Disorder
    • 2023 TLM Debrief Sessions
    • State of the Art Programs

  • Product not yet rated Contains 2 Component(s)

    Moderators: Mary Thomson, MD; Kali Zhou, MD, MAS Speakers: Gia Landry, MD, Tatyana Kushner, MD, MSCE

    During this webinar, the speakers will describe two unique populations and the practical aspects and health systems models needed to treat hepatitis C: pregnant and incarcerated people. The emerging data regarding safety and efficacy of treating hepatitis C during pregnancy will be discussed, as well as the effects on maternal to child transmission. There will also be discussion on the individual opportunities and challenges of treating hepatitis C in incarcerated people, as well as the downstream community effects of treating hepatitis C in this setting. Lastly, there will be an overview of the Louisiana Corrections Model, which is a successful example of using policy to overcome gaps in the corrections system.

    Mary Thomson (Moderator)

    Dr. Thomson is an Assistant Professor in the Division of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota. Dr. Thomson’s clinical and research interests include health care delivery in cirrhosis and early identification of alcohol-related liver disease, particularly in women. She is on the AASLD Public Health SIG steering committee. She received an AASLD Transplant Hepatology Grant to fund her clinical research efforts. 

    Gia Landry, MD (Moderator)

    Dr. Gia Landry is director of hepatology for The Liver Center Ochsner Baton Rouge and clinical assistant professor of medicine at Louisiana State University Health Science Center. She is the clinical expert for the Louisiana Department of Health’s initiative to eliminate hepatitis C (HCV). The HCV elimination initiative is one of the first of its kind in the United States, where a state is working toward eliminating hepatitis C as a public health threat. In this role she helps create training documents and provides training to primary providers around the state of Louisiana to treat hepatitis C, along with implementation and training within the Department of Corrections. She has published multiple peer reviewed articles on HCV elimination, hepatitis C, hepatitis B and hepatocellular carcinoma. 

    Tatyana Kushner, MD, MSCE

    Dr. Kushner is an Associate Professor in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai and holds a joint appointment in the Department of Obstetrics, Gynecology and Reproductive Sciences. Her research addresses understanding the epidemiology and outcomes in individuals living with viral hepatitis, particularly among individuals of childbearing age and pregnancy. She is a member of the AASLD/ IDSA HCV Guidance committee, a member of the Global NASH Council Viral Hepatitis Committee, and Chair of the AASLD Women's Initiative Committee. She is founder and director of the Mount Sinai Women’s Liver Clinic which is a clinic co-located on the Obstetrics Department and provides dedicated care to individuals living with viral hepatitis and other liver conditions during pregnancy and postpartum.  

  • Product not yet rated Contains 1 Component(s)

    Hosted by the Portal Hypertension SIG

    This activity was originally aired:  3/12/2024

    Moderators: Patrick Northup, MD, FAASLD

    Speakers: Constantine Karvellas, MD, SM, FRCPC, FCCM, Brian Buchanan

  • Contains 5 Component(s)

    Plenary Lectures from the Annual Meeting

    3067: President's Choice State of the Art Lecture: Digitized Medicine

    3069: Thomas E. Starzl Liver Transplant State of the Art Lecture: Alcohol-Associated Liver Disease: Transplant Triumphs and Challenges

    3102: Hyman J. Zimmerman State of the Art: New Diagnostic Approaches in Acetaminophen Acute Liver Injury

    3060: Leon Schiff State of the Art: Personalized Approach to HCC

  • Contains 9 Component(s)

    Postgraduate Course

    This is the Postgraduate Course which includes:

  • Contains 7 Component(s)



    Rebecca Wells, MD: Basic Science Debrief

    Juan Albraldes, MD: Portal Hypertension Debrief

    Jennifer Price, MD, PhD: Hepatitis Debrief

    Gideon Hirschfield, FRCP PhD: Cholestasis Debrief

    Mazen Noureddin, MD, MHSc: MASLD Debrief

  • Contains 3 Product(s)

    View on-demand presentations from The Liver Meeting® 2023.

    View on-demand presentations from The Liver Meeting® 2023. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics. 

  • Product not yet rated Contains 1 Component(s)

    2024 Webinar

    Originally aired: 2/06/2024

    Hosted by:  Inclusion and Diversity Committee

    Moderator: Chimaobi Anugwom, MBBS
    Speaker: Julius Wilder, MD, PhD; Lorna Dove, MD, MPH